A similar pattern was noticed with tirzepatide while in the SURMOUNT-four demo — participants who switched from tirzepatide to placebo regained a considerable percentage of their body weight more than 36 months. Like with any med, tirzepatide has prospective Unintended effects. The commonest are gastrointestinal, for example:What this tells us �